Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ian Shaw appointed to Advisory Board

2 Mar 2012 13:45

RNS Number : 6088Y
Quindell Portfolio PLC
02 March 2012
 



Immediate Release

 

 

Quindell Portfolio Plc

("Quindell" or the "Company")

 

APPOINTMENT OF IAN SHAW TO THE

STRATEGY AND INTEGRATION ADVISORY BOARD

 

Quindell Portfolio Plc (AIM: QPP.L), the brand extension company and a leading practice provider of consultancy, software and outsourcing in its key markets, is pleased to announce the appointment of Ian Shaw to its Strategy and Integration Advisory Board.

Ian has 33 years experience working within the IT industry, with over 20 of these spent with Bupa. During his career with BupaIan held the positions of Head of Applications Development and Support, Chief Services Officer and Chief Systems Officer, and directed the IT service for a range of business areas, including UK Insurance with a turnover of £1.5billion per annum and Group functions with staffing of over 400.

In his capacity of Head of Applications Development and Support, Ian was instrumental in the design and deployment of a new £10million Customer Service environment, which introduced a pre-authorisation model to the industry, resulting in major increases in customer satisfaction and contributing significantly to Bupa's ten year period of high market share and sustained profitable performance.

Since leaving Bupa in 2010, Ian has extended his work into the Public Sector, working with a number of NHS Foundation Trusts, focussing on transformation through business insight and information governance.

Rob Terry, Chairman and Chief Executive of Quindell said:

"We are delighted to welcome Ian to our Strategy and Integration Advisory Board. Ian brings with him a wealth of experience in driving strategic initiatives and business transformation within the health sector and we look forward to working with him to test the opportunity for introducing 'pre-authorisation' into the personal injury marketplace."

 

Commenting on the appointment, Ian Shaw said:

"There is a clear opportunity to introduce new approaches to the personal injury and rehabilitation marketplaces and I am personally very excited to be working with Quindell,who are uniquely placed to bring real change to the industry, through the development of the Mobile Doctors' offerings and their innovative use of their own leading practice technologies."

 

For further information:

 

Quindell Portfolio PlcRob Terry, Chairman & Chief Executive

 

Laurence Moorse, Group Finance Director

Tel: 01329 830 501

terryr@quindell.com

Tel: 01329 830 543

moorsel@quindell.com

Cenkos Securities plc (Nominated adviser and broker) Stephen Keys /Adrian Hargrave (Corporate Finance)

Alex Aylen / Andy Roberts (Sales)

 

Tel: 020 7397 8900

 

Media EnquiriesRedleafPolhill Limited

Rebecca Sanders-Hewett

Jenny Bahr

 

Quindell Portfolio PlcGillian Baker, Investor Relations

 

 

Tracey Terry, Chief Communications Officer

 

 

Tel: 020 7566 6720

quindell@redleafpolhill.com

 

 

Tel:01329836724 

bakerg@quindell.com

 

Tel: 01329 830 501

terrylt@quindell.com

 

Notes to Editors:

 

About Quindell Portfolio Plc

Quindell, the Brand Extension Company, helps its clients and partners to utilise their brands enabling them to achieve greater sales, provide better service and extend the brand into new product offerings and alternative routes to market.

 

The Group works with over 2,000 brands from SMEs to blue-chips around the globe, with solutions applying to the following Sectors & related Supply Chains:

 

·; Telecoms, Utilities, Retail & E-commerce

·; Finance, Insurance, Health & Legal

·; Government & Public Sector

 

Quindell Portfolio joined the market through Mission Capital Plc. The Group was readmitted to the market on 17 May 2011 following the acquisition of Quindell Limited. On 18 July 2011, the Company was renamed Quindell Portfolio Plc. In December 2011, Mobile Doctors Group Plc was acquired increasing run-rate revenue to over £50 million and staff levels to over 600 including our off-shore capability.

 

Our Solutions

In addition to extending our clients' brands, Quindell's solutions are focused on generating improvements in efficiency and effectiveness in sales and service transactions with savings of over 20% against industry norms achieved.

 

Our Consultancy drives the business transformation for our clients, and is supported by leading edge technology, outsourcing, membership schemes and social media via repeatable solutions.

 

Our Software provides cloud based industry solutions to deliver the necessary framework to meet online, office and field based sales and service expectations of our clients and their customers.

 

Our "Sales" Technology Enabled Outsourcing leverages our own Business & Home Advisory Service brands to provide a White Labeled proposition for partners to extend into offerings for Telecoms, Utilities, Finance, Insurance, Health and Legal Services.

 

Our "Service" Technology Enabled Outsourcing covers a broad range of solutions and in insurance, already recognised as a market leader for independent medical evidence via a panel of circa 2,500 medical experts providing circa 11% of reports for UK Personal Injury claims.

 

For further information, please visit www.quindell.com 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSVVSIFIIF
Date   Source Headline
20th Feb 20187:00 amRNSHolding(s) in Company
26th Jan 20187:00 amRNSPre-close trading update
3rd Jan 20184:19 pmRNSHolding(s) in Company
3rd Jan 20184:18 pmRNSHolding(s) in Company
2nd Jan 20187:00 amRNSBoard Appointment and Resignation
18th Dec 201710:31 amRNSHolding(s) in Company
7th Dec 20177:58 amRNSChange of Registered Office
7th Dec 20177:00 amRNSChange of Registered Office
4th Dec 20172:26 pmRNSHolding(s) in Company
3rd Nov 201711:59 amRNSHolding(s) in Company
2nd Nov 20177:00 amRNSHolding(s) in Company
16th Oct 20172:51 pmRNSHolding(s) in Company
12th Oct 20174:30 pmRNSDefence to claim by Slater and Gordon (UK) 1 Ltd
28th Sep 201710:16 amRNSHolding(s) in Company
27th Sep 20177:00 amRNSDirector/PDMR Shareholding
21st Sep 201710:52 amRNSHolding(s) in Company
20th Sep 20177:01 amRNSResults for the six months ended 30 June 2017
4th Sep 201711:05 amRNSHolding(s) in Company
31st Aug 201712:32 pmRNSHolding(s) in Company
1st Aug 20175:15 pmRNSHolding(s) in Company
31st Jul 20174:04 pmRNSHolding(s) in Company
27th Jul 201711:05 amRNSHolding(s) in Company
20th Jul 20175:03 pmRNSHolding(s) in Company
12th Jul 201710:28 amRNSHolding(s) in Company
27th Jun 201710:43 amRNSAGM Statement and Results
27th Jun 20177:00 amRNSBoard Appointment
14th Jun 20177:00 amRNSClaim by Slater and Gordon (UK) 1 Limited
8th Jun 20177:00 amRNSHolding(s) in Company
6th Jun 20172:27 pmRNSHolding(s) in Company
31st May 20174:00 pmRNSHolding(s) in Company
26th May 20177:00 amRNSHolding(s) in Company
22nd May 20177:00 amRNSHolding(s) in Company
16th May 20174:00 pmRNSHolding(s) in Company
16th May 20173:29 pmRNSHolding(s) in Company
16th May 20177:00 amRNSHolding(s) in Company
15th May 20176:00 pmRNSHolding(s) in Company
15th May 201712:21 pmRNSHolding(s) in Company
12th May 20174:32 pmRNSHolding(s) in Company
12th May 20172:46 pmRNSHolding(s) in Company
11th May 20177:00 amRNSProspective claim by Slater and Gordon
10th May 20177:00 amRNSHolding(s) in Company
5th May 20177:18 amRNSAnnual Financial Report
27th Apr 20177:00 amRNSPreliminary results for the year ended 31 Dec 2016
21st Apr 20177:00 amRNSHolding(s) in Company
20th Apr 20174:54 pmRNSHolding(s) in Company
12th Apr 20174:35 pmRNSPrice Monitoring Extension
28th Mar 20177:00 amRNSHolding(s) in Company
23rd Mar 20177:00 amRNSDirector Declaration
23rd Mar 20177:00 amRNSHolding(s) in Company
15th Mar 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.